REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,254,305 | +16.7% | 51,533 | +4.0% | 1.02% | +12.3% |
| Q1 2023 | $4,503,177 | +240.4% | 49,529 | +484.0% | 0.91% | +223.5% |
| Q2 2020 | $1,323,000 | +24.7% | 8,481 | +15.4% | 0.28% | -12.2% |
| Q1 2020 | $1,061,000 | -66.5% | 7,351 | -52.5% | 0.32% | -50.8% |
| Q4 2019 | $3,163,000 | – | 15,472 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |